| Literature DB >> 33738436 |
Carolyn T Jordan1, Emily M Bradford2, Dennis C Cheek3, Mahesh Kudrimoti3, Craig S Miller4, Molly H Smith5, J Zach Hilt1, Thomas D Dziubla1.
Abstract
Translational animal models for oral mucositis (OM) are necessary to simulate and assess the bioclinical effects and response in humans. These models should simulate high levels of radiation exposure that leads to oxidative stress and inflammatory-initiated tissue changes. Hamster models have been extensively studied to observe pathological effects of radiation exposure and help in the development of effective treatments. To successfully evaluate the potential for treatment regimens with consistency and relevance, a radiation-induced OM hamster model was developed using a clinical linear accelerator utilized by cancer patients daily. The dose exposure to the isolated, everted cheek pouch of a hamster, as well as the progression of injury, pro-inflammatory marker, histological, and elasticity analyses of the buccal pouch were conducted to verify replicability and reproducibility of the injury model. The findings from this model demonstrated its ability to consistently induce injury and resolution over 28 days using an acute dose of 60 Gy. This model was developed to enhance clinical relevance when evaluating potential efficacious treatments and can now be utilized in efficacy studies to better evaluate developed therapeutics in a preclinical model that is easy to translate to clinical studies..Entities:
Keywords: animal models; radiotherapy; stomatitis
Year: 2021 PMID: 33738436 PMCID: PMC7954840 DOI: 10.1002/ame2.12148
Source DB: PubMed Journal: Animal Model Exp Med ISSN: 2576-2095
FIGURE 1Hamster pouches everted and isolated by acrylic clamps designed for localized exposure to the field using the LINAC
Modified rubric based on Sonis et al. to evaluate progression of observational injury of the duration of the study
| Score | Description |
|---|---|
| 0 | Pouch completely healthy. No erosion or vasodilation. |
| 1 | Erythema. Slight fibrosis between days 19 and 28. |
| 2 | Severe erythema, vasodilation, and superficial erosion. Fibrosis present between days 19 and 28. |
| 3 | Formation of ulcer, plaque covered ulcer, exophytic mass, or fibrotic tissue (in days 19‐28 only) in one or more places, but not affecting more than 25% of the surface area of the pouch. Severe erythema and vasodilation. |
| 4 | Cumulative ulcer formation, plaque covered ulcer, exophytic mass, or fibrotic tissue (in days 19‐28 only)) in ~50% of pouch surface area. |
| 5 | Complete ulceration, plaque formation, exophytic mass, or fibrotic tissue (in day 19‐28 only) covering the entire pouch and/or unable to extract. |
FIGURE 2Method development of the RIOM using the LINAC. Experimental setup of the injury model (A), Dose‐dependent pilot study to evaluate injury at 20 (n = 2), 40, and 60 Gy (n = 4 for 40 and 60 Gy) (B), progression and evaluation of injury of a positive control in a large‐scale animal study (n = 22) (C), and cheek pouch images of injury on days 0, 18, and 28 (D). Error bars depict Mean ± SEM
FIGURE 3End point analysis at day 28. Normalized quantitative values of extraction widths of irradiated cheek pouches at day 0 (start), day 18 (peak injury), and end (day 27) (A). Hematoxylin and eosin staining of a baseline cheek pouch compared to an irradiated cheek pouch at day 28. Black arrow represents intact/healthy epithelium, blue arrow represents inflammatory infiltrate, and white arrow represents disrupted epithelium. Representative images are shown at 10x magnification. (B). Oxidative and inflammatory biomarker analysis at day 28 of 60 Gy exposure compared to basal levels (C). (n = 22, Mean ± SEM) *represents significance (P < .05)